172 related articles for article (PubMed ID: 1511745)
21. Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase.
Wedlock N; Asawa T; Baumann-Antczak A; Smith BR; Furmaniak J
FEBS Lett; 1993 Oct; 332(1-2):123-6. PubMed ID: 8405426
[TBL] [Abstract][Full Text] [Related]
22. Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy.
Laureti S; Falorni A; Volpato M; Casucci G; Picchio ML; Angeletti G; Luthman H; Brunetti P; Betterle C; Santeusanio F
Horm Metab Res; 1996 Jul; 28(7):319-22. PubMed ID: 8858375
[TBL] [Abstract][Full Text] [Related]
23. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
[TBL] [Abstract][Full Text] [Related]
24. Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I.
Uibo R; Perheentupa J; Ovod V; Krohn KJ
J Autoimmun; 1994 Jun; 7(3):399-411. PubMed ID: 7916911
[TBL] [Abstract][Full Text] [Related]
25. Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies.
Chen S; Sawicka J; Prentice L; Sanders JF; Tanaka H; Petersen V; Betterle C; Volpato M; Roberts S; Powell M; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1998 Aug; 83(8):2977-86. PubMed ID: 9709979
[TBL] [Abstract][Full Text] [Related]
26. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Zanchetta R; Greggio NA; Pedini B; Boscaro M; Presotto F
J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
[TBL] [Abstract][Full Text] [Related]
27. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase.
Krohn K; Uibo R; Aavik E; Peterson P; Savilahti K
Lancet; 1992 Mar; 339(8796):770-3. PubMed ID: 1347802
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side-chain cleavage and 17alpha-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III.
de Carmo Silva R; Kater CE; Dib SA; Laureti S; Forini F; Cosentino A; Falorni A
Eur J Endocrinol; 2000 Feb; 142(2):187-94. PubMed ID: 10664529
[TBL] [Abstract][Full Text] [Related]
29. [Radioimmunologic determination of pituitary autoantibodies in patients with Addison's disease].
Gryczyńska M; Kosowicz J
Endokrynol Pol; 1991; 42(4):561-6. PubMed ID: 1364507
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease.
Söderbergh A; Rorsman F; Halonen M; Ekwall O; Björses P; Kämpe O; Husebye ES
J Clin Endocrinol Metab; 2000 Jan; 85(1):460-3. PubMed ID: 10634424
[TBL] [Abstract][Full Text] [Related]
31. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease.
Freeman M; Weetman AP
Clin Exp Immunol; 1992 May; 88(2):275-9. PubMed ID: 1572092
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies in autoimmune polyendocrine syndrome type II.
Falorni A; Laureti S; Santeusanio F
Endocrinol Metab Clin North Am; 2002 Jun; 31(2):369-89, vii. PubMed ID: 12092456
[TBL] [Abstract][Full Text] [Related]
33. Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding.
Asawa T; Wedlock N; Baumann-Antczak A; Smith BR; Furmaniak J
J Clin Endocrinol Metab; 1994 Aug; 79(2):372-6. PubMed ID: 8045950
[TBL] [Abstract][Full Text] [Related]
34. [Idiopathic Addison's disease].
Takebe K
Horumon To Rinsho; 1974 May; 22(5):589-94. PubMed ID: 4608811
[No Abstract] [Full Text] [Related]
35. Autoimmune Addison's disease and 21-hydroxylase.
Baumann-Antczak A; Wedlock N; Bednarek J; Kiso Y; Krishnan H; Fowler S; Smith BR; Furmaniak J
Lancet; 1992 Aug; 340(8816):429-30. PubMed ID: 1353582
[No Abstract] [Full Text] [Related]
36. High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.
Dawoodji A; Chen JL; Shepherd D; Dalin F; Tarlton A; Alimohammadi M; Penna-Martinez M; Meyer G; Mitchell AL; Gan EH; Bratland E; Bensing S; Husebye ES; Pearce SH; Badenhoop K; Kämpe O; Cerundolo V
J Immunol; 2014 Sep; 193(5):2118-26. PubMed ID: 25063864
[TBL] [Abstract][Full Text] [Related]
37. Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases.
Colls J; Betterle C; Volpato M; Prentice L; Smith BR; Furmaniak J
Clin Chem; 1995 Mar; 41(3):375-80. PubMed ID: 7882511
[TBL] [Abstract][Full Text] [Related]
38. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility.
Partanen J; Peterson P; Westman P; Aranko S; Krohn K
Hum Immunol; 1994 Oct; 41(2):135-40. PubMed ID: 7860358
[TBL] [Abstract][Full Text] [Related]
39. Expression of the addisonian autoantigen in human adrenal tumors.
Winqvist O; Rastad J; Tibell AK; Karlsson FA; Kämpe O
Autoimmunity; 1993; 16(3):173-80. PubMed ID: 8003612
[TBL] [Abstract][Full Text] [Related]
40. Precipitating anti-adrenal antibodies in Addison's disease.
Krohn K; Perheentupa J; Heinonen E
Clin Immunol Immunopathol; 1974 Sep; 3(1):59-68. PubMed ID: 4215605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
